Australia markets open in 2 hours 25 minutes

Abiomed, Inc. (ABMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
281.42+2.92 (+1.05%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close278.50
Open277.59
Bid271.85 x 800
Ask281.97 x 900
Day's range276.37 - 281.89
52-week range119.01 - 319.19
Volume202,810
Avg. volume304,965
Market cap12.677B
Beta (5Y monthly)1.17
PE ratio (TTM)81.03
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Analysts Estimate Abiomed (ABMD) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Abiomed (ABMD) to Report a Decline in Earnings: What to Look Out for

    Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Abiomed's Heart Pump Can Improve Outcomes in Some Patients
    Motley Fool

    Abiomed's Heart Pump Can Improve Outcomes in Some Patients

    New trial data supports the use of the company's Impella heart pumps in high-risk patients undergoing surgery to treat their coronary heart disease.

  • Is Abiomed Stock a Buy?
    Motley Fool

    Is Abiomed Stock a Buy?

    Abiomed (NASDAQ: ABMD) struggled in 2019, but the stock has risen more than 62% so far this year. Abiomed's devices all have to do with the circulatory system, including the world's smallest heart pump, the Impella. Since the company acquired the Impella technology by buying German company Impella CardioSystems in 2005, Abiomed's revenue has risen every year.